- Nachrichtendetail
-
24.06.2024 13:57:55 - dpa-AFX: *BIOGEN'S TOFIDENCE BIOSIMILAR RECEIVES EC APPROVAL FOR MULTIPLE INDICATIONS INCL. COVID-19 TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Biogen | 789617 | NASDAQ | 225,580 | 05.07.24 22:00:00 | +0,970 | +0,43% | 221,500 | 225,740 | 225,030 | 224,610 |
